Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support
Article
López-Martínez, N, Segú, JL, Vázquez-Castro, J et al. (2017). Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support
. 17(2), 141-148. 10.1080/14737167.2017.1290525
López-Martínez, N, Segú, JL, Vázquez-Castro, J et al. (2017). Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support
. 17(2), 141-148. 10.1080/14737167.2017.1290525
Introduction: Diabetes mellitus affects 13.8% of the adult population in Spain, representing some 8.2% of total Spanish health spending, which may be reduced by optimizing treatment and disease monitoring. Areas covered: This perspective article aims to evaluate the possible clinical and economic outcomes of implementing a theoretical personalized care model in diabetes supported by information and communications technology in Spain vs. conventional care. Moreover, we assessed the value of emminens® eConecta, a solution designed to support the operational implementation of this model, which enables the connection and participation of patients and health professionals, facilitates patient education, decision-making, access to information, and data analysis. We carried out a review of the available evidence, consultations with experts and a clinical and cost estimation. Expert commentary: The experts consulted considered that the proposed model is consistent with Spanish strategies on chronicity, supports the management of chronicity/diabetes, and may improve the most important aspects of disease management. In the literature, this type of care models improved or provided equal disease control compared with conventional care, potentiated self-management strategies and reduced the high use of resources. Cost estimation showed a reduction of −12% in total direct costs and around −34% in the costs of outpatient visits.
